A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer
NCT05643885
·
clinicaltrials.gov ↗
COMPLETED
Status
7304
Enrollment
INDUSTRY
Sponsor class
Conditions
Thromboembolism
Sponsor
Pfizer
Collaborators
[object Object]